Bioaffinity Technologies, INC. (BIAFW) SEC Filings — 2025
47 SEC filings for Bioaffinity Technologies, INC. (BIAFW) in 2025.
Filings
- bioAffinity Technologies Files 8-K — 8-K · Dec 22, 2025
- bioAffinity Technologies Files 8-K — 8-K · Dec 19, 2025
- Bioaffinity Technologies, INC. 8-K Filing — 8-K · Dec 3, 2025
- bioAffinity's Losses Double Amid Revenue Dip, Cash Influx from Offerings — 10-Q · Nov 14, 2025
- Bioaffinity Technologies, INC. DEFA14A Filing — DEFA14A · Nov 12, 2025
- BioAffinity Seeks Shareholder Nod for Major Dilution, Equity Plan Boost — DEF 14A · Nov 7, 2025
- Bioaffinity Technologies, INC. 8-K Filing — 8-K · Nov 5, 2025
- bioAffinity Technologies Files 8-K — 8-K · Oct 28, 2025
- bioAffinity Technologies Files 8-K — 8-K · Oct 20, 2025
- bioAffinity Technologies Files 8-K — 8-K · Oct 16, 2025
- bioAffinity Technologies Files 8-K — 8-K · Oct 15, 2025
- bioAffinity Technologies Files 8-K with Material Agreement — 8-K · Oct 9, 2025
- bioAffinity Technologies Files 8-K — 8-K · Oct 7, 2025
- bioAffinity Technologies Files 8-K — 8-K · Sep 30, 2025
- bioAffinity Offers Shares Amid Nasdaq Delisting Threat, Reverse Split — S-1/A · Sep 25, 2025
- bioAffinity Launches Equity Offering Post-Split; No Minimum Raises Risk — S-1 · Sep 24, 2025
- bioAffinity Technologies Files 8-K on Corporate Changes — 8-K · Sep 17, 2025
- bioAffinity Files S-1/A for Resale of 32.5M Shares by Selling Holders — S-1/A · Sep 15, 2025
- bioAffinity Technologies Files 8-K — 8-K · Sep 9, 2025
- bioAffinity Technologies to be Acquired — 8-K · Sep 5, 2025
- bioAffinity Technologies Files 8-K — 8-K · Sep 3, 2025
- bioAffinity Technologies Files 8-K — 8-K · Sep 2, 2025
- bioAffinity Files S-1 for Resale of 12.6M Shares by Selling Stockholders — S-1 · Aug 29, 2025
- bioAffinity Technologies Announces Board and Executive Changes — 8-K · Aug 18, 2025
- bioAffinity's Losses Widen Amid Revenue Drop, Going Concern Doubts — 10-Q · Aug 14, 2025
- bioAffinity Technologies Faces Delisting Concerns — 8-K · Aug 13, 2025
- bioAffinity Technologies Files 8-K — 8-K · Jul 31, 2025
- bioAffinity Technologies Files 8-K on Security Holder Vote Matters — 8-K · Jul 25, 2025
- bioAffinity Technologies Files 8-K — 8-K · Jul 23, 2025
- bioAffinity Technologies Files 8-K — 8-K · Jul 22, 2025
- bioAffinity Technologies Files 8-K Report — 8-K · Jul 15, 2025
- bioAffinity Pushes Early Lung Cancer Dx; Annual Meeting Set — DEF 14A · Jun 2, 2025
- bioAffinity Technologies Faces Delisting Notice — 8-K · May 30, 2025
- bioAffinity Technologies Enters Material Definitive Agreement — 8-K · May 27, 2025
- bioAffinity Technologies Files 8-K on Shareholder Nominations — 8-K · May 19, 2025
- bioAffinity Technologies Q1 2025 10-Q Filing — 10-Q · May 15, 2025
- bioAffinity Technologies Files 8-K — 8-K · May 8, 2025
- bioAffinity Technologies Files S-1/A Amendment — S-1/A · May 5, 2025
- bioAffinity Technologies Files S-1 for Public Offering — S-1 · May 2, 2025
- bioAffinity Technologies Files 10-K Amendment — 10-K/A · Apr 29, 2025
- bioAffinity Technologies Announces Board and CFO Changes — 8-K · Apr 14, 2025
- bioAffinity Technologies Files S-1 for Public Offering — S-1 · Apr 11, 2025
- bioAffinity Technologies Files 2024 10-K — 10-K · Mar 31, 2025
- bioAffinity Technologies Closes $1.5M Private Placement — 8-K · Mar 7, 2025
- bioAffinity Technologies Files 8-K with Key Agreements — 8-K · Feb 27, 2025
- bioAffinity Technologies Faces Delisting Notice — 8-K · Feb 7, 2025
- bioAffinity Tech Appoints New Director, CEO Gets New Contract — 8-K · Jan 14, 2025